BMJ Publishing Group Acta Medica Okayama 2044-6055 12 6 2022 Patients' acceptability and implementation outcomes of a case management approach to encourage participation in colorectal cancer screening for people with schizophrenia: a qualitative secondary analysis of a mixed-method randomised clinical trial e060621 EN Yuto Yamada Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Masaki Fujiwara Department of Neuropsychiatry, Okayama University Hospital Taichi Shimazu Division of Behavioral Sciences, National Cancer Center Institute for Cancer Control Tsuyoshi Etoh Department of Nursing, Shimane University Hospital Masafumi Kodama Okayama Psychiatric Medical Center Ryuhei So Okayama Psychiatric Medical Center Takanori Matsushita Zikei Hospital Yusaku Yoshimura Zikei Hospital Shigeo Horii Zikei Hospital Maiko Fujimori Division of Supportive Care, Survivorship and Translational Research, National Cancer Center Institute for Cancer Control Hirokazu Takahashi Division of Screening Assessment and Management, National Cancer Center Institute for Cancer Control Naoki Nakaya Tohoku Medical Megabank Organization, Tohoku University Tempei Miyaji Department of Clinical Trial Data Management, Graduate School of Medicine, The University of Tokyo Shiro Hinotsu Department of Biostatistics and Data Management, Sapporo Medical University Keita Harada Department of Gastroenterology, Okayama University Hospital Hiroyuki Okada Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Yosuke Uchitomi Group for Supportive Care and Survivorship Research, National Cancer Center Institute for Cancer Control Norihito Yamada Department of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Masatoshi Inagaki Department of Psychiatry, Faculty of Medicine, Shimane University Objectives We examined the efficacy of case management (CM) interventions to encourage participation in colorectal cancer screening for patients with schizophrenia. This study aimed to clarify patients' acceptability of the intervention and the helpful components of the intervention. Simultaneously, the study aimed to determine the acceptability, appropriateness and feasibility of the intervention from the perspective of psychiatric care providers. Study design and setting This study was a secondary qualitative analysis of a mixed-method randomised controlled trial that evaluated the efficacy of the CM approach to encourage participation in cancer screening for people with schizophrenia. The intervention comprised education and patient navigation for colorectal cancer screening. Interviews were conducted with patients who received the intervention and staff from two psychiatric hospitals in Japan who delivered the intervention. Participants Of the 172 patients with schizophrenia who participated in the trial, 153 were included. In addition, three out of six providers were included. Data collection and analysis Using a structured interview, the case manager asked participants about patient acceptability and the helpful components of the intervention. Content analysis was conducted for the responses obtained, and the number of responses was tabulated by two researchers. For the interviews with the providers, opinions obtained from verbatim transcripts were extracted and summarised. Results Forty-three of the 56 patients perceived that the intervention was acceptable. For the intervention component, inperson counselling with an explanation of the screening process by psychiatric care providers was most frequently reported by the patients as helpful (48 of the 68 respondents). Psychiatric care providers evaluated the intervention as acceptable, appropriate and easy to understand and administer. However, providing the intervention to all patients simultaneously was considered difficult with the current human resources. Conclusions This study showed that the CM intervention was perceived as acceptable by patients and acceptable and appropriate by psychiatric care providers. No potential conflict of interest relevant to this article was reported.

岡山医学会 Acta Medica Okayama 0030-1558 122 2 2010 精神腫瘍学概論 119 124 EN Yosuke Uchitomi No potential conflict of interest relevant to this article was reported.